Checked
Fate Therapeutics Inc
Nasdaq: FATE · Biological Products, (No Diagnostic Substances) · San Diego, CA
- Revenue
- $6.65M
- -51.2% vs. prior year
- Net income
- -$136.3M
- -2051.1% net margin
- Total assets
- $318.9M
- Diluted EPS
- -$1.15
Company details
As reported to the SEC
- SEC CIK
- 1434316
- Stock
- Nasdaq: FATE
- Legal Entity Identifier (LEI)
- 549300L14Q4UHOODLA90
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) (2836)
- Headquarters
- 12278 Scripps Summit Drive, San Diego, CA 92131
- Fiscal year end (SEC record)
- December 31
- Filer status
- Non-accelerated filer, Smaller reporting company
- Phone
- (858) 875-1803
- Employer ID (EIN)
- 65-1311552
- Last annual report
- 02/26/2026
- Last quarterly report
- 08/13/2026
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Revenue | $6.65M | $13.63M | $63.53M | $96.3M | $55.85M |
| Operating income | -$147.7M | -$210.3M | -$190.5M | -$308.4M | -$217M |
| Net income | -$136.3M | -$186.3M | -$160.9M | -$281.7M | -$212.2M |
| Diluted earnings per share | -$1.15 | -$1.64 | -$1.64 | -$2.91 | -$2.24 |
| Research and development | $107.8M | $135M | $172.6M | $320.5M | $215.5M |
| Total assets | $318.9M | $440.7M | $506.2M | $705.6M | $921.5M |
| Shareholders' equity | $207.2M | $318.7M | $368.4M | $483.9M | $678.8M |
| Cash and cash equivalents | $46.63M | $36.06M | $41.87M | $61.33M | $133.6M |
| Cash from operations | -$106.1M | -$122.9M | -$132.3M | -$248.2M | -$162.9M |
| Capital expenditures | $5.95M | $730K | $6.15M | $35.57M | $50.7M |
Federal and state records filed under the name Fate Therapeutics Inc
Matched by the company name and by the subsidiary names it lists in SEC filings and other public records, after removing endings like Inc., Corp. and Holdings. Records marked Subsidiary were filed under a subsidiary name. A subsidiary that is not listed in those records is not included, and an unrelated business with the same name can appear.
Work visa sponsorship
Certified H-1B and PERM green card filings with the Department of Labor
| Employer on filing | H-1B | PERM |
|---|---|---|
| Fate Therapeutics, IncSan Diego, CA | 2 | 0 |
Recent filings
138 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
31 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Fate Therapeutics Inc in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other biological products, (no diagnostic substances)
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Amgen IncAMGN | Thousand Oaks, CA | $36.75B | $7.71B |
| Gilead Sciences, Inc.GILD | Foster City, CA | $29.44B | $8.51B |
| Biogen Inc.BIIB | Cambridge, MA | $9.89B | $1.29B |
| Neurocrine Biosciences IncNBIX | San Diego, CA | $2.86B | $478.6M |
| Exelixis, Inc.EXEL | Alameda, CA | $2.32B | $782.6M |
| Qiagen N.V.QGEN | Pl Venlo, Netherlands | $2.09B | $424.9M |
| Moderna, Inc.MRNA | Cambridge, MA | $1.94B | -$2.82B |
| Halozyme Therapeutics, Inc.HALO | San Diego, CA | $1.4B | $316.9M |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Fate Therapeutics Inc's CIK number?
- Fate Therapeutics Inc's SEC Central Index Key (CIK) is 1434316.
- What is Fate Therapeutics Inc's stock ticker?
- Fate Therapeutics Inc trades as Nasdaq: FATE.
- What was Fate Therapeutics Inc's revenue?
- Fate Therapeutics Inc reported revenue of $6.65M for the fiscal year ended Dec 31, 2025, -51.2% from the year before.
- When does Fate Therapeutics Inc's fiscal year end?
- Fate Therapeutics Inc's fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is Fate Therapeutics Inc headquartered?
- Fate Therapeutics Inc's principal executive office on file with the SEC is in San Diego, CA.
- Does Fate Therapeutics Inc sponsor H-1B visas?
- Department of Labor records show 2 certified H-1B filings and 0 certified PERM filings under the name Fate Therapeutics Inc.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026